MedTrace Logo

CEFID-I (CEra Flow Improves DVT-1)

NCT05469282 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2026-02-09

No results posted yet for this study

Summary

The study is a single center clinical trial to evaluate the efficacy and safety of blood circulation improvement using an investigational medical device, which is a product on the market and it's name is Ceragem Master V6, for the risk group of Deep Vein Thrombosis (DVT) and the ordinary person. The study compares before and after the application by one time application.

Conditions

  • Blood Circulation Disorder
  • Deep Vein Thrombosis

Interventions

DEVICE

Blood circulation device

Blood circulation device of CGM MB-1701 (Ceragem Master V6)

Sponsors & Collaborators

  • Ceragem Clinical Inc.

    lead INDUSTRY

Principal Investigators

  • Yong Soon Yoon, MD · Presbyterian medical center

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-22
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05469282 on ClinicalTrials.gov